Literature DB >> 6766902

Dengue-2 vaccine: preparation from a small-plaque virus clone.

K H Eckels, V R Harrison, P L Summers, P K Russell.   

Abstract

The S-1 clone of dengue type 2 virus was used for the preparation of a live-attenuated vaccine after passage in DBS-FRhL-2 cell culture. The vaccine virus had a relatively higher replicative capacity at superoptimal temperatures than its precursor virus, S-1, passaged in primary green monkey kidney cells (S-1 PGMK). There was also a tendency for the S-1 vaccine virus to exhibit leakiness at increased temperatures. Another in vitro marker, replication in monkey peripheral blood leukocytes, indicated less host restriction for the S-1 vaccine in comparative assays with S-1 PGMK virus. Mouse virulence appeared to remain stable on passage in DBS-FRhL-2 cells, whereas monkey immunogenicity decreased. Cautious trials of the dengue type 2 S-1 vaccine in humans are indicated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6766902      PMCID: PMC550740          DOI: 10.1128/iai.27.1.175-180.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  STUDIES ON JAPANESE B ENCEPHALITIS VIRUS VACCINES FROM TISSUE CULTURE. IV. PREPARATION AND CHARACTERIZATION OF POOL OF ATTENUATED OCT-541 LINE FOR HUMAN VACCINE TRIAL.

Authors:  W M HAMMON; S ROHITAYODHIN; J S RHIM
Journal:  J Immunol       Date:  1963-09       Impact factor: 5.422

2.  Two variants of tick-borne encephalitis virus showing different plaque morphology.

Authors:  V MAYER
Journal:  Virology       Date:  1963-06       Impact factor: 3.616

3.  Clinical and serologic response of man to immunization with attenuated dengue and yellow fever viruses.

Authors:  W R DORRANCE; J W FRANKEL; I GORDON; P R PATTERSON; R W SCHLESINGER; J W WINTER
Journal:  J Immunol       Date:  1956-11       Impact factor: 5.422

4.  A spontaneous temperature sensitive mutant of Japanese encephalitis virus: preliminary characterization.

Authors:  S Halle; E Zebovitz
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

5.  Development of a diploid cell line from fetal rhesus monkey lung for virus vaccine production.

Authors:  R E Wallace; P J Vasington; J C Petricciani; H E Hopps; D E Lorenz; Z Kadanka
Journal:  In Vitro       Date:  1973 Mar-Apr

6.  Pandemic dengue in Caribbean countries and the southern United States--past, present and potential problems.

Authors:  N J Ehrenkranz; A K Ventura; R R Cuadrado; W L Pond; J E Porter
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

7.  Demonstration of infectious DNA in transformed cells. II. Characterization of uptake of SV40-transformed mouse cell DNA by simian cells.

Authors:  R K Kelly; J S Butel
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

8.  Chemically induced temperature-sensitive mutants of dengue virus type 2: comparison of temperature sensitivity in vitro with infectivity suckling mice, hamsters, and rhesus monkeys.

Authors:  G C Tarr; A S Lubiniecki
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

9.  Dengue-2 vaccine: viremia and immune responses in rhesus monkeys.

Authors:  R M Scott; A Nisalak; K H Eckels; M Tingpalapong; V R Harrison; D J Gould; F E Chapple; P K Russell
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

10.  PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE.

Authors:  A B Sabin; R W Schlesinger
Journal:  Science       Date:  1945-06-22       Impact factor: 47.728

View more
  19 in total

1.  Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses.

Authors:  Y S Hahn; E M Lenches; R Galler; C M Rice; J Dalrymple; J H Strauss
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice.

Authors:  Alexander A Rumyantsev; Brian R Murphy; Alexander G Pletnev
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes.

Authors:  Kathryn A Hanley; Jay J Lee; Joseph E Blaney; Brian R Murphy; Stephen S Whitehead
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3.

Authors:  F Preugschat; C W Yao; J H Strauss
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Fetal rhesus monkey lung cells can be grown in serum-free medium for the replication of dengue-2 vaccine virus.

Authors:  B Malewicz; L E Anderson; K Crilly; H M Jenkin
Journal:  In Vitro Cell Dev Biol       Date:  1985-08

6.  Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.

Authors:  J E Blaney; D H Johnson; C Y Firestone; C T Hanson; B R Murphy; S S Whitehead
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 7.  The dengue viruses.

Authors:  E A Henchal; J R Putnak
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

8.  Sequence of the dengue virus type 2 (strain PR-159) NS1 gene and comparison with its vaccine derivative.

Authors:  H Leblois; P R Young
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

9.  Antibody response to dengue-2 vaccine measured by two different radioimmunoassay methods.

Authors:  P L Summers; K H Eckels; J M Dalrymple; R M Scott; V A Boyd
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

10.  Temperature-sensitive events during the replication of the attenuated S-1 clone of dengue type 2 virus.

Authors:  K H Eckels; P L Summers; P K Russell
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.